近日，广东证监局要求某上市公司2个交易日内更换董事长，原因是该公司董事长被多地法院列入失信 被执行人名单。这凸显出个别上市公司的治理乱象，值得各方深刻反思。 《公司法》第178条规定不得担任公司董监高的情形，就包括"个人因所负数额较大债务到期未清偿被人 民法院列为失信被执行人"情形。该公司在董事会决议公告、年报半年报中只字不提董事长这些污点， 如此情形下的老赖还厚着脸皮、堂而皇之担任上市公司董事长。只要自己不尴尬，尴尬的就是别人。试 想一下，老赖成为上市公司掌舵人，上市公司在市场的信用、信誉必将蒙尘，公司要有好的发展前景恐 怕很难。 《上市公司独立董事管理办法》规定，董事会中设置提名委员会的，提名委员会应当对被提名人任职资 格进行审查，并形成明确的审查意见；提名委员会中，独立董事应当过半数并担任召集人。本案上市公 司董事会提名委员会是否尽到对被提名人任职资格的把关责任，值得关注，当然，如果候选人隐瞒失信 等相关信息，提名委员会能否发现，不得而知。 建议证券监管部门可与最高人民法院、国家发改委等部门联手建立失信信息共享机制，这有利于对被列 入失信名单人士实施任职限制。再进一步，可由证券监管部门牵头建立全国性的上 ...

中证投服中心A股上市公司2024年年度股东会专项行权已正式收官。证券时报记者获悉，上市公司股东 会召开季，中证投服中心围绕内控机制建设、独立董事作用发挥、上市公司内部追责机制建立等方面对 21家高风险公司展开质询建议，累计抛出82个核心问题。 中证投服中心相关负责人表示，参加股东会，行使股东知情权、建议权、质询权，是中证投服中心服务 中小投资者、有效保护中小投资者合法权益的重要渠道和有力抓手。 聚焦三方面 对于高风险公司被查处的违规行为内部追责问题，中证投服中心在参会过程中同样予以重点关注。中证 投服中心现场质询时，要求部分尚未进行内部追责的公司董事会详细说明具体原因和后续计划，充分保 障中小投资者的知情权。 21家高风险公司 现场抛出82个核心问题 作为中小股东的"代言人"，中证投服中心今年将高风险公司作为股东会专项行权的重点对象。据了解， 21家高风险公司由中证投服中心会同沪深交易所以及证监会相关派出机构共同选定，皆因资金占用、财 务舞弊等违法违规行为遭受行政处罚，并被实施风险警示。 在股东会现场，中证投服中心主要围绕三个方面问题对21家高风险公司展开质询，并提出建议。中证投 服中心累计抛出82个核心问题 ...

Core Points - The company aims to enhance its corporate governance structure by establishing a set of rules for independent directors, in accordance with relevant laws and regulations [1][4] - Independent directors are defined as those who do not hold any other positions within the company and have no direct or indirect interests that could affect their independent judgment [1][2] - The company will hold special meetings exclusively for independent directors to ensure independent decision-making [3][4] Summary by Sections Independent Director Meetings - Special meetings for independent directors must be convened by a majority of independent directors, and if the convenor is unable to fulfill their duties, two or more independent directors can call the meeting [2] - Independent directors are required to attend these meetings in person or review materials beforehand if unable to attend [2][3] Special Powers and Responsibilities - Certain special powers, such as hiring external consultants for audits or proposing meetings, require approval from a special meeting of independent directors [2][3] - Specific matters, including related party transactions and changes to commitments, must be discussed in these special meetings before being submitted to the board [2][3] Record Keeping and Confidentiality - Independent directors must maintain detailed work records of their duties, which include meeting records and communications with company staff [3] - The company is responsible for providing support for these meetings and covering necessary expenses for independent directors [3][4] - All attending independent directors have a confidentiality obligation regarding the matters discussed in the meetings [3]

General Provisions - The audit committee is established to enhance the supervision of financial information, internal control, and auditing processes within the company [1][2] - The audit committee operates independently and is not subject to interference from other departments or individuals within the company [1][2] Composition of the Audit Committee - The audit committee consists of three directors, with a majority being independent directors, and must include a professional accountant as the chairperson [2][3] - Members must possess relevant professional knowledge and experience, ensuring they can effectively oversee and evaluate internal and external audit work [3][4] Responsibilities and Authority - The main responsibilities of the audit committee include reviewing financial information, supervising external and internal audits, and ensuring effective internal controls [5][6] - The committee has the authority to propose the hiring or replacement of external auditors and to evaluate their performance [6][8] Meeting Procedures - The audit committee is required to hold regular meetings at least quarterly, with additional meetings called as necessary [32][33] - A quorum of two-thirds of the members is required for meetings to proceed, and decisions are made based on majority votes [40][46] Decision-Making and Reporting - Decisions made by the audit committee must be documented and reported to the board of directors, including any dissenting opinions [54][56] - The committee is responsible for tracking the implementation of its decisions and ensuring compliance with legal and regulatory requirements [58][59] Conflict of Interest - Members with a conflict of interest must recuse themselves from discussions and votes related to the matter [61][63] - The committee must ensure that decisions are made without the influence of interested parties [62][63] Miscellaneous Provisions - The rules established for the audit committee are subject to national laws and regulations, as well as the company's articles of association [66][67] - The rules take effect upon approval by the board of directors [67]

Core Points - The company is holding its second extraordinary general meeting of shareholders in 2025 on July 10, 2025, at 14:30 [6][8] - The agenda includes proposals for changing registered capital, abolishing the supervisory board, and amending the company's articles of association [8][9] - The company plans to increase its registered capital from RMB 200 million to RMB 260 million through profit distribution and capital reserve conversion [8][9] - The supervisory board will be abolished, and its functions will be transferred to the audit committee of the board of directors [9][10] - The company will nominate candidates for the fourth board of directors, including both non-independent and independent directors [12][14] Meeting Procedures - Attendees must register to verify their shareholder status, and the meeting will be conducted with both on-site and online voting [2][3] - The voting will include both named voting for non-cumulative proposals and cumulative voting for board member elections [3][6] - The meeting will be presided over by the chairman, who will manage the order of speeches and voting [5][7] Proposals - Proposal 1: Change of registered capital, abolition of the supervisory board, and amendment of the articles of association [8][9] - Proposal 2: Nomination of candidates for the fourth board of directors, including non-independent directors [12][13] - Proposal 3: Nomination of candidates for independent directors for the fourth board of directors [14][23]

Core Points - The document outlines the management system for the shares held by directors and senior management of Anhui Huaren Health Pharmaceutical Co., Ltd, emphasizing the need for compliance with relevant laws and regulations [2][3][12] - It specifies the procedures for reporting share transactions by directors and senior management, including timelines for notification and disclosure [4][5][20] - The document establishes restrictions on the transfer of shares by directors and senior management, including limits on the number of shares that can be sold within a year and conditions under which shares cannot be transferred [6][8][19] Group 1 - The management system is established to enhance the oversight of shares held by directors and senior management, in accordance with the Company Law and Securities Law [2][3] - Directors and senior management must notify the board secretary in writing before buying or selling shares, and the board secretary is responsible for managing and verifying the information [4][12] - The document outlines the calculation of transferable shares, stating that newly acquired shares can only be transferred under specific conditions [3][5] Group 2 - Restrictions on share transfers include a maximum of 25% of total shares held per year and a six-month lock-up period after leaving the company [4][6][19] - Certain conditions prohibit directors and senior management from trading shares, such as during the period before financial report announcements and when under investigation for violations [8][18] - The document mandates that any changes in shareholding must be reported to the Shenzhen Stock Exchange within two trading days, including details of the transaction [20][9]

Core Viewpoint - The China Securities Investor Services Center has nominated independent director candidates for Shangfeng Cement, marking the second public nomination of independent directors in A-shares, aimed at enhancing the participation of small and medium investors in corporate governance [1][2]. Group 1 - The nomination of independent directors by the China Securities Investor Services Center broadens the sources of nominations and protects the legal rights of small and medium investors [1][2]. - This initiative follows the State Council's April 2023 issuance of guidelines to improve the independent director nomination system, encouraging investor protection institutions to publicly solicit shareholder rights [1]. - The China Securities Investor Services Center's actions represent a shift from "recommendations by a few" to "participation by market entities" in the nomination process [1]. Group 2 - The public nomination enhances the transparency and fairness of independent director elections, effectively safeguarding the rights of small investors in corporate governance [2]. - Shangfeng Cement has announced a shareholder meeting to review the independent director nomination proposal, urging investors to participate in the public solicitation of voting rights [2]. - Investors can find specific participation methods in the solicitation announcement and can express support by voting in favor if they miss the public solicitation [2].

广州御银科技股份有限公司 第一章 总则 第一条 为了规范广州御银科技股份有限公司（以下简称"公司"）治理，加强 公司董事、高级管理人员的离职管理，保障公司治理稳定性及股东合法权益， 根据《中华人民共和国公司法》（以下简称《公司法》）《上市公司章程指引》 等有关法律、法规和规范性文件和《广州御银科技股份有限公司章程》（以下简 称"《公司章程》"）的规定，制定本制度。 第二条 本制度适用于公司全体董事（含独立董事）及高级管理人员的辞任、 任期届满、解任等离职情形。 第二章 离职情形与生效条件 第三条 董事可以在任期届满以前提出辞任。董事辞任应向公司提交书面辞职 报告，公司收到辞职报告之日起辞任生效，公司将在两个交易日内披露有关情况。 如因董事的辞任导致公司董事会成员低于法定最低人数时，或者独立董事辞职 导致独立董事人数少于董事会成员的三分之一、独立董事中没有会计专业人士、专 门委员会中独立董事所占的比例不符合法律、行政法规、部门规章和《公司章程》 规定，辞职报告应当在下任董事填补因其辞任产生的空缺后方能生效。在改选出的 董事就任前，原董事仍应当依照法律、行政法规、部门规章和《公司章程》规定， 履行董事职务。 第四 ...

Core Points - The document outlines the management system for the shares held by directors and senior management of Guangzhou Yuyin Technology Co., Ltd, ensuring compliance with relevant laws and regulations [1][2][9] Summary by Sections Management Regulations - The management system is established to regulate the shares held by directors and senior management, based on the Company Law, Securities Law, and other relevant regulations [1] - Directors and senior management must adhere to this system [2] Share Transfer Restrictions - Shares held by directors and senior management cannot be transferred under certain conditions, including within one year of the company's stock listing and within six months after leaving the company [1][2] - Additional restrictions apply if the company is under investigation for securities violations or if the individual is subject to administrative penalties [2] Trading Restrictions - Directors and senior management are prohibited from trading company stocks during specific periods, such as 15 days before the annual or semi-annual report announcements and 5 days before quarterly reports [2][5] Reporting and Disclosure - Directors and senior management must report any changes in their shareholdings within two trading days and ensure accurate and timely disclosure of their trading activities [7][8] - The company secretary is responsible for managing the identity and shareholding data of directors and senior management [8] Compliance and Penalties - Violations of the management system may result in disciplinary actions by the board, and serious breaches could lead to penalties from regulatory authorities [9][9] - The document emphasizes the importance of compliance with the Securities Law regarding the sale and purchase of shares within specified timeframes [6][10]

独立董事提名人声明与承诺 提名人朱蓉娟， 现提名祖启为北海国发川山生物股份有限公司第十 一 届董事 会独立董事候选人， 并已充分了解被提名人职业、 学历、 职称、 详细的工作经历、 全部兼职、 有无重大失信等不良记录等情况。 被提名人已同意出任北海国发川山 生物股份有限公司第十 一 届董事会独立董事候选人（参见该独立董事候选人声 明）。 提名人认为， 被提名人具备独立董事任职资格， 与北海国发川山生物股份 有限公司之间不存在任何影响其独立性的关系， 具体声明并承诺如下： 一、 被提名入具备上市公司运作的基本知识， 熟悉相关法律、 行政法规、 规 章及其他规范性文件， 具有5年以上法律、 经济、 会计、 财务、 管理或者其他履 行独立董事职责所必需的工作经验。 被提名人已经参加培训并取得证券交易所认可的相关培训证明材料。 、 上海证券交易所自律监 管规则以及公司章程有关独立董事任职资格和条件的相关规定； （四）中共中央纪委、 中共中央组织部《关千规范中管干部辞去公职或者退 （离）休后担任上市公司、 基金管理公司独立董事、 独立监事的通知》的规定 （如适用）； （五）中共中央组织部《关千进 一 步规范党政领导干部 ...